Skip to main content

Mercyhealth Now Offering FDA-Approved Automated Breast Ultrasound Screening

Mercyhealth Now Offering FDA-Approved Automated Breast Ultrasound Screening

What's new at Mercyhealth | Thursday, September 2, 2021

Mercyhealth is now offering the Invenia™ ABUS 2.0 (Automated Breast Ultrasound System), approved by the FDA for breast cancer screening as an adjunct to mammography for women with dense breast tissue.

“We are excited to add the Automated Breast Ultrasound system from GE Healthcare to our comprehensive breast cancer screening program. By offering ABUS in addition to mammography for our patients with dense breast tissue, we anticipate improving detection for small cancers that cannot be seen on a mammogram alone in these women. We believe ABUS will become an integral part of our practice for the detection of breast cancer,” said Patrick F. Para, DO, FAOCR, FACR, diagnostic radiologist at Mercyhealth.

Dense breast tissue has been found to be the most common risk factor for the development of cancer and also makes cancer more difficult to detect using mammography, according to multiple large studies. As breast density goes up, the accuracy of mammograms goes down. The difficulty radiologists experience when reading mammograms is that both dense tissue and cancer appear white on a mammogram.

In early 2019, a national density inform law was passed that mandates that the FDA update mammography reporting so that women be notified if their breasts are dense. Providers may offer supplemental imaging as appropriate to help find cancers hiding in dense breast tissue.

The Invenia ABUS 2.0 system is designed to enhance the consistency, reproducibility, and sensitivity of breast ultrasound. Studies using ABUS have demonstarted a 35.7 percent improvement in cancer detection (sensitivity) in women with dense breasts without prior breast intervention.

Mercyhealth recommends that women get regular mammograms starting at 40 years old as suggested by their doctor, and if they have been informed that they have dense breast tissue, they should talk to their doctor or radiologist about their specific risk and additional screening tests that might be appropriate.

About Mercyhealth: Mercyhealth is a multi-regional health system with more than 700 employed physician partners, seven hospitals and 85 primary and specialty care locations serving 55 northern Illinois and southern Wisconsin communities. Mercyhealth’s over 7,000 employee/partners care for over 2.4 million patient visits each year. As the top vertically integrated health care provider, they continuously work with a passion for making lives better for the people, families and communities they serve.